BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19969054)

  • 1. Liposomes as delivery systems for antibiotics.
    Drulis-Kawa Z; Dorotkiewicz-Jach A
    Int J Pharm; 2010 Mar; 387(1-2):187-98. PubMed ID: 19969054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal drug delivery systems--clinical applications.
    Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
    Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress of liposomes as antibiotic carriers].
    Yang D; Xu Y; Li F; Liu H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Nov; 26(11):1387-90. PubMed ID: 23230678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes and lipid carriers in the treatment of microbial infections.
    Bakker-Woudenberg IA; Lokerse AF
    Scand J Infect Dis Suppl; 1990; 74():34-41. PubMed ID: 2097717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ectericide as a dispersion medium for the preparation of prospective clinical liposomal drug forms].
    Dikiĭ IL; Strel'nikov LS; Chueshov VI; Iakovenko VD; Bazavluk AD
    Vestn Akad Med Nauk SSSR; 1990; (6):40-4. PubMed ID: 2220037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomes as carriers for antibiotics.
    Nacucchio MC; Di Rocco PH; Sordelli DO
    Targeted Diagn Ther; 1990; 3():337-54. PubMed ID: 2131016
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study.
    Rukholm G; Mugabe C; Azghani AO; Omri A
    Int J Antimicrob Agents; 2006 Mar; 27(3):247-52. PubMed ID: 16472992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
    Alipour M; Halwani M; Omri A; Suntres ZE
    Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery systems to increase the selectivity of antibiotics in phagocytic cells.
    Briones E; Colino CI; Lanao JM
    J Control Release; 2008 Feb; 125(3):210-27. PubMed ID: 18077047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug delivery system for infectious diseases].
    Maesaki S; Kohno S
    Nihon Rinsho; 1998 Mar; 56(3):752-61. PubMed ID: 9549369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-circulating sterically stabilized liposomes in the treatment of infections.
    Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L
    Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
    Huh AJ; Kwon YJ
    J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections.
    Gamazo C; Prior S; Concepción Lecároz M; Vitas AI; Campanero MA; Pérez G; Gonzalez D; Blanco-Prieto MJ
    Expert Opin Drug Deliv; 2007 Nov; 4(6):677-88. PubMed ID: 17970669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of experimental osteomyelitis by liposomal antibiotics.
    Kadry AA; Al-Suwayeh SA; Abd-Allah AR; Bayomi MA
    J Antimicrob Chemother; 2004 Dec; 54(6):1103-8. PubMed ID: 15486079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome encapsulation: a method for enhancing the effectiveness of local antibiotics.
    Price CI; Horton JW; Baxter CR
    Surgery; 1994 Apr; 115(4):480-7. PubMed ID: 8165539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of antibiotic treatment of patient with a severe bacterial infection].
    Aubert G; Carricajo A
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):704-13. PubMed ID: 15324959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.